NMPA Approval

Amoxicillin Sodium and Clavulanate Potassium for Injection Ⅱ

Approval Number

国药准字H20234480

Company深圳华润九新药业有限公司

Registration Date

December 29, 2023

Drug Information

Generic Name

注射用阿莫西林钠克拉维酸钾(Ⅱ)

Dosage Form

注射剂

Strength

2.2g（C₁₆H₁₉N₃O₅S 2.0g与C₈H₉NO₅ 0.2g）

Drug Type

化学药品

Registration Date

December 29, 2023

Company Information

Applicant Company

Company Name深圳华润九新药业有限公司

Company Address

深圳市福田区上梅林工业区凯丰路2号

Manufacturing Company

Company Name中孚药业股份有限公司

Company Address

山东省潍坊市寒亭区禹王北街2709号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用阿莫西林钠克拉维酸钾(Ⅱ) - NMPA 批准文号 | MedPath